Cart
sales@molnova.com
Gonadorelin Acetate
CAS No. 71447-49-9
Gonadorelin Acetate( Luteinizing Hormone Releasing Hormone (LH-RH) human | Luteinizing Hormone Releasing Hormone (LH-RH) )
Catalog No. M19827 CAS No. 71447-49-9
Gonadorelin Acetate is hypothalamic neuropeptide which plays a key role in the control of reproductive functions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 68 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 388 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 919 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGonadorelin Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGonadorelin Acetate is hypothalamic neuropeptide which plays a key role in the control of reproductive functions.
-
DescriptionGonadorelin Acetate is hypothalamic neuropeptide which plays a key role in the control of reproductive functions.
-
In Vitro——
-
In Vivo——
-
SynonymsLuteinizing Hormone Releasing Hormone (LH-RH) human | Luteinizing Hormone Releasing Hormone (LH-RH)
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
Recptor5-α reductase
-
Research AreaMetabolic Disease
-
IndicationTuberculosis
Chemical Information
-
CAS Number71447-49-9
-
Formula Weight1302.39
-
Molecular FormulaC59H83N17O17
-
Purity>98% (HPLC)
-
SolubilityWater:10 mM
-
SMILESCC(O)=O.CC(O)=O.CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moretti RM et al. Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression. Endocr Relat Cancer. 2003 Jun;10(2):161-7.
molnova catalog
related products
-
CH5138303
CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
-
WJ-39
WJ-39 is an orally active aldose reductase (AR) inhibitor that ameliorates renal lesions in diabetic nephropathy through activation of Nrf2 signaling, and may be used to ameliorate renal insufficiency and fibrosis.
-
Izonsteride
Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.
